541 related articles for article (PubMed ID: 34774023)
1. Fusobacterium nucleatum and oral cancer: a critical review.
McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
[TBL] [Abstract][Full Text] [Related]
2. About a Possible Impact of Endodontic Infections by
Ciani L; Libonati A; Dri M; Pomella S; Campanella V; Barillari G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791123
[TBL] [Abstract][Full Text] [Related]
3. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells.
Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y
Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795
[TBL] [Abstract][Full Text] [Related]
4. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
[TBL] [Abstract][Full Text] [Related]
5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
6. Involvement of
Fujiwara N; Kitamura N; Yoshida K; Yamamoto T; Ozaki K; Kudo Y
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867334
[TBL] [Abstract][Full Text] [Related]
7. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
Metzger Z; Blasbalg J; Dotan M; Weiss EI
J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
[TBL] [Abstract][Full Text] [Related]
8. Carcinogenesis mechanisms of Fusobacterium nucleatum.
Gholizadeh P; Eslami H; Kafil HS
Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
Brennan CA; Garrett WS
Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
[TBL] [Abstract][Full Text] [Related]
10.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
11. Synergistic pathogenicity of Porphyromonas gingivalis and Fusobacterium nucleatum in the mouse subcutaneous chamber model.
Metzger Z; Lin YY; Dimeo F; Ambrose WW; Trope M; Arnold RR
J Endod; 2009 Jan; 35(1):86-94. PubMed ID: 19084132
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
13. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation.
Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V
Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761
[TBL] [Abstract][Full Text] [Related]
14. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
[TBL] [Abstract][Full Text] [Related]
15. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
16.
Rubinstein MR; Baik JE; Lagana SM; Han RP; Raab WJ; Sahoo D; Dalerba P; Wang TC; Han YW
EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30833345
[No Abstract] [Full Text] [Related]
17. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
Slade DJ
Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240
[TBL] [Abstract][Full Text] [Related]
18. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
19. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.
Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM
Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489
[TBL] [Abstract][Full Text] [Related]
20. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
Liu PF; Huang IF; Shu CW; Huang CM
Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
